1 – 20 of 45
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Arachidonic acid and docosahexaenoic acid levels correlate with the inflammation proteome in extremely preterm infants
(
- Contribution to journal › Article
- 2023
-
Mark
Visual outcome at 2.5 years of age in ω-3 and ω-6 long-chain polyunsaturated fatty acid supplemented preterm infants : a follow-up of a randomized controlled trial
(
- Contribution to journal › Article
-
Mark
The development of blood protein profiles in extremely preterm infants follows a stereotypic evolution pattern
(
- Contribution to journal › Article
-
Mark
Hyper high haemoglobin content in red blood cells and erythropoietic transitions postnatally in infants of 22 to 26 weeks' gestation: a prospective cohort study
(
- Contribution to journal › Article
-
Mark
Modification of serum fatty acids in preterm infants by parenteral lipids and enteral docosahexaenoic acid/arachidonic acid : A secondary analysis of the Mega Donna Mega trial
(
- Contribution to journal › Article
- 2022
-
Mark
Preterm infant circulating sex steroid levels are not altered by transfusion with adult male plasma : a retrospective multicentre cohort study
(
- Contribution to journal › Article
- 2021
-
Mark
Effect of Enteral Lipid Supplement on Severe Retinopathy of Prematurity : A Randomized Clinical Trial
(
- Contribution to journal › Article
-
Mark
Analysis of Brain Injury Biomarker Neurofilament Light and Neurodevelopmental Outcomes and Retinopathy of Prematurity among Preterm Infants
(
- Contribution to journal › Article
- 2020
-
Mark
Elevated levels of IL-6 and IGFBP-1 predict low serum IGF-1 levels during continuous infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants
(
- Contribution to journal › Article
-
Mark
IGF1, serum glucose, and retinopathy of prematurity in extremely preterm infants
(
- Contribution to journal › Article
-
Mark
Randomized Control Trial of Postnatal rhIGF-1/rhIGFBP-3 Replacement in Preterm Infants : Post-hoc Analysis of Its Effect on Brain Injury
(
- Contribution to journal › Article
- 2019
-
Mark
rhIGF-1/rhIGFBP-3 in Preterm Infants : A Phase 2 Randomized Controlled Trial
(
- Contribution to journal › Article
-
Mark
C-Peptide Suppression during Insulin Infusion in the Extremely Preterm Infant Is Associated with Insulin Sensitivity
(
- Contribution to journal › Article
- 2018
-
Mark
Photoreceptor glucose metabolism determines normal retinal vascular growth
(
- Contribution to journal › Article
-
Mark
Relation of Retinopathy of Prematurity to Brain Volumes at Term Equivalent Age and Developmental Outcome at 2 Years of Corrected Age in Very Preterm Infants
(
- Contribution to journal › Article
-
Mark
Early Electroencephalography Suppression and Postnatal Morbidities Correlate with Cerebral Volume at Term-Equivalent Age in Very Preterm Infants
(
- Contribution to journal › Article
-
Mark
Increased postnatal concentrations of pro-inflammatory cytokines are associated with reduced IGF-I levels and retinopathy of prematurity
(
- Contribution to journal › Article
- 2017
-
Mark
Development and verification of a pharmacokinetic model to optimize physiologic replacement of rhIGF-1/rhIGFBP-3 in preterm infants
(
- Contribution to journal › Article
-
Mark
Continuous longitudinal infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants : Evaluation of feasibility in a phase II study
(
- Contribution to journal › Article
-
Mark
IGF-1 as a Drug for Preterm Infants : A Step-Wise Clinical Development
(
- Contribution to journal › Scientific review